İleri Evre Hepatosellüler Karsinom Tedavisinde Transarteryel Radyoembolizasyon Sonrası Bilgisayarlı Tomografi Perfüzyon Görüntüleme Parametreleri Değişimi
Referanslar
El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 2012. 142(6): 1264-1273.
Kennedy A, Coldwell D, Sangro B, Wasan H, Salem R. Integrating radioembolization ((90)Y microspheres) into current treatment options for liver tumors: introduction to the international working group report. American journal of clinical oncology. 2012;35(1):81-90. doi:10.1097/COC.0b013e3181ec60b8
Sangro, B., Iñarrairaegui, M., & Bilbao, J. I. (2012). Radioembolization for hepatocellular carcinoma. Journal of hepatology, 56(2), 464–473. https://doi.org/10.1016/j.jhep.2011.07.012
Amorim J, França M, Perez-Girbes A, Torregrosa A, Martí-Bonmatí L. Critical review of HCC imaging in the multidisciplinary setting: treatment allocation and evaluation of response. Abdominal radiology (New York). 2020;45(10):3119-3128. doi:10.1007/s00261-020-02470-1
Kim SH, Kamaya A. Willmann JK. CT perfusion of the liver: principles and applications in oncology. Radiology, 2014. 272(2): 322-44.
Spina JC, Hume I, Pelaez A, Peralta O, Quadrelli M, Garcia Monaco R. Expected and Unexpected Imaging Findings after 90Y Transarterial Radioembolization for Liver Tumors. Radiographics. 2019;39(2):578-595. doi:10.1148/rg.2019180095
Miyayama S, Matsui O, Zen Y, et al. Portal blood supply to locally progressed hepatocellular carcinoma after transcatheter arterial chemoembolization: Observation on CT during arterial portography. Hepatology research : the official journal of the Japan Society of Hepatology. 2011;41(9):853-866. doi:10.1111/j.1872-034X.2011.00836.x
Ippolito D, Querques G, Okolicsanyi S, Franzesi CT, Strazzabosco M, Sironi S. Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study. European journal of radiology. 2017;90:34-41. doi:10.1016/j.ejrad.2017.02.027
Morsbach F, Pfammatter T, Reiner CS, et al. Computed tomographic perfusion imaging for the prediction of response and survival to transarterial radioembolization of liver metastases. Investigative radiology. 2013;48(11):787-794. doi:10.1097/RLI.0b013e31829810f7
Borgheresi A, Gonzalez-Aguirre A, Brown KT, et al. Does Enhancement or Perfusion on Preprocedure CT Predict Outcomes After Embolization of Hepatocellular Carcinoma? Academic radiology. 2018;25(12):1588-1594. doi:10.1016/j.acra.2018.02.027
Marquez HP, Karalli A, Haubenreisser H, et al. Computed tomography perfusion imaging for monitoring transarterial chemoembolization of hepatocellular carcinoma. European journal of radiology. 2017;91:160-167. doi:10.1016/j.ejrad.2017.03.014
Reiner CS, Morsbach F, Sah BR, et al. Early treatment response evaluation after yttrium-90 radioembolization of liver malignancy with CT perfusion. Journal of vascular and interventional radiology. 2014;25(5):747-759. doi:10.1016/j.jvir.2014.01.025
Ippolito D, Fior D, Bonaffini PA, et al. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients. European journal of radiology. 2014;83(9):1665-1671. doi:10.1016/j.ejrad.2014.05.040
Kennedy A, Coldwell D, Sangro B, Wasan H, Salem R. Integrating radioembolization ((90)Y microspheres) into current treatment options for liver tumors: introduction to the international working group report. American journal of clinical oncology. 2012;35(1):81-90. doi:10.1097/COC.0b013e3181ec60b8
Sangro, B., Iñarrairaegui, M., & Bilbao, J. I. (2012). Radioembolization for hepatocellular carcinoma. Journal of hepatology, 56(2), 464–473. https://doi.org/10.1016/j.jhep.2011.07.012
Amorim J, França M, Perez-Girbes A, Torregrosa A, Martí-Bonmatí L. Critical review of HCC imaging in the multidisciplinary setting: treatment allocation and evaluation of response. Abdominal radiology (New York). 2020;45(10):3119-3128. doi:10.1007/s00261-020-02470-1
Kim SH, Kamaya A. Willmann JK. CT perfusion of the liver: principles and applications in oncology. Radiology, 2014. 272(2): 322-44.
Spina JC, Hume I, Pelaez A, Peralta O, Quadrelli M, Garcia Monaco R. Expected and Unexpected Imaging Findings after 90Y Transarterial Radioembolization for Liver Tumors. Radiographics. 2019;39(2):578-595. doi:10.1148/rg.2019180095
Miyayama S, Matsui O, Zen Y, et al. Portal blood supply to locally progressed hepatocellular carcinoma after transcatheter arterial chemoembolization: Observation on CT during arterial portography. Hepatology research : the official journal of the Japan Society of Hepatology. 2011;41(9):853-866. doi:10.1111/j.1872-034X.2011.00836.x
Ippolito D, Querques G, Okolicsanyi S, Franzesi CT, Strazzabosco M, Sironi S. Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study. European journal of radiology. 2017;90:34-41. doi:10.1016/j.ejrad.2017.02.027
Morsbach F, Pfammatter T, Reiner CS, et al. Computed tomographic perfusion imaging for the prediction of response and survival to transarterial radioembolization of liver metastases. Investigative radiology. 2013;48(11):787-794. doi:10.1097/RLI.0b013e31829810f7
Borgheresi A, Gonzalez-Aguirre A, Brown KT, et al. Does Enhancement or Perfusion on Preprocedure CT Predict Outcomes After Embolization of Hepatocellular Carcinoma? Academic radiology. 2018;25(12):1588-1594. doi:10.1016/j.acra.2018.02.027
Marquez HP, Karalli A, Haubenreisser H, et al. Computed tomography perfusion imaging for monitoring transarterial chemoembolization of hepatocellular carcinoma. European journal of radiology. 2017;91:160-167. doi:10.1016/j.ejrad.2017.03.014
Reiner CS, Morsbach F, Sah BR, et al. Early treatment response evaluation after yttrium-90 radioembolization of liver malignancy with CT perfusion. Journal of vascular and interventional radiology. 2014;25(5):747-759. doi:10.1016/j.jvir.2014.01.025
Ippolito D, Fior D, Bonaffini PA, et al. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients. European journal of radiology. 2014;83(9):1665-1671. doi:10.1016/j.ejrad.2014.05.040
Sayfalar
31-38
Gelecek
27 Ocak 2025
Telif Hakkı (c) 2025 Akademisyen Yayınevi Kitap DOI Portalı
